HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $246,000 | -2.4% | 6,170 | -1.6% | 0.01% | +14.3% |
| Q4 2021 | $252,000 | -0.8% | 6,270 | +0.6% | 0.01% | -12.5% |
| Q3 2021 | $254,000 | -10.9% | 6,235 | -0.8% | 0.01% | -11.1% |
| Q2 2021 | $285,000 | -16.2% | 6,285 | -22.9% | 0.01% | -18.2% |
| Q1 2021 | $340,000 | -9.1% | 8,150 | -7.0% | 0.01% | -15.4% |
| Q4 2020 | $374,000 | -38.7% | 8,760 | -62.3% | 0.01% | -43.5% |
| Q3 2020 | $610,000 | – | 23,220 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |